106 related articles for article (PubMed ID: 30266107)
1. Comparison of β-Amyloid Plaque Labeling Methods: Antibody Staining, Gallyas Silver Staining, and Thioflavin-S Staining.
Shi XZ; Wei X; Sha LZ; Xu Q
Chin Med Sci J; 2018 Sep; 33(3):167-173. PubMed ID: 30266107
[TBL] [Abstract][Full Text] [Related]
2. The effect of focal brain injury on beta-amyloid plaque deposition, inflammation and synapses in the APP/PS1 mouse model of Alzheimer's disease.
Collins JM; King AE; Woodhouse A; Kirkcaldie MT; Vickers JC
Exp Neurol; 2015 May; 267():219-29. PubMed ID: 25747037
[TBL] [Abstract][Full Text] [Related]
3. Imaging and Spectral Characteristics of Amyloid Plaque Autofluorescence in Brain Slices from the APP/PS1 Mouse Model of Alzheimer's Disease.
Gao Y; Liu Q; Xu L; Zheng N; He X; Xu F
Neurosci Bull; 2019 Dec; 35(6):1126-1137. PubMed ID: 31127445
[TBL] [Abstract][Full Text] [Related]
4. Magnetic resonance imaging of amyloid plaques using hollow manganese oxide nanoparticles conjugated with antibody aβ1-40 in a transgenic mouse model.
Kim JH; Ha TL; Im GH; Yang J; Seo SW; Lee IS; Lee JH
Neuroreport; 2013 Jan; 24(1):16-21. PubMed ID: 23168564
[TBL] [Abstract][Full Text] [Related]
5. Maysin and Its Flavonoid Derivative from Centipedegrass Attenuates Amyloid Plaques by Inducting Humoral Immune Response with Th2 Skewed Cytokine Response in the Tg (APPswe, PS1dE9) Alzheimer's Mouse Model.
Song Y; Kim HD; Lee MK; Hong IH; Won CK; Bai HW; Lee SS; Lee S; Chung BY; Cho JH
PLoS One; 2017; 12(1):e0169509. PubMed ID: 28072821
[TBL] [Abstract][Full Text] [Related]
6. β-Amyloid, cholinergic transmission, and cerebrovascular system -- a developmental study in a mouse model of Alzheimer's disease.
Kuznetsova E; Schliebs R
Curr Pharm Des; 2013; 19(38):6749-65. PubMed ID: 23530514
[TBL] [Abstract][Full Text] [Related]
7. Treadmill exercise enhances synaptic plasticity, but does not alter β-amyloid deposition in hippocampi of aged APP/PS1 transgenic mice.
Zhao G; Liu HL; Zhang H; Tong XJ
Neuroscience; 2015 Jul; 298():357-66. PubMed ID: 25917310
[TBL] [Abstract][Full Text] [Related]
8. Prion-like propagation of β-amyloid aggregates in the absence of APP overexpression.
Ruiz-Riquelme A; Lau HHC; Stuart E; Goczi AN; Wang Z; Schmitt-Ulms G; Watts JC
Acta Neuropathol Commun; 2018 Apr; 6(1):26. PubMed ID: 29615128
[TBL] [Abstract][Full Text] [Related]
9. Diffuse amyloid deposition, but not plaque number, is reduced in amyloid precursor protein/presenilin 1 double-transgenic mice by pathway lesions.
van Groen T; Liu L; Ikonen S; Kadish I
Neuroscience; 2003; 119(4):1185-97. PubMed ID: 12831872
[TBL] [Abstract][Full Text] [Related]
10. IFN-γ Production by amyloid β-specific Th1 cells promotes microglial activation and increases plaque burden in a mouse model of Alzheimer's disease.
Browne TC; McQuillan K; McManus RM; O'Reilly JA; Mills KH; Lynch MA
J Immunol; 2013 Mar; 190(5):2241-51. PubMed ID: 23365075
[TBL] [Abstract][Full Text] [Related]
11. Butyrylcholinesterase is associated with β-amyloid plaques in the transgenic APPSWE/PSEN1dE9 mouse model of Alzheimer disease.
Darvesh S; Cash MK; Reid GA; Martin E; Mitnitski A; Geula C
J Neuropathol Exp Neurol; 2012 Jan; 71(1):2-14. PubMed ID: 22157615
[TBL] [Abstract][Full Text] [Related]
12. An Aβ3-10-KLH vaccine reduced Alzheimer's disease-like pathology and had a sustained effect in Tg-APPswe/PSEN1dE9 mice.
Meng Y; Ding L; Zhang HY; Yin WC; Yan Y; Cao YP
Brain Res; 2017 Oct; 1673():72-77. PubMed ID: 28779977
[TBL] [Abstract][Full Text] [Related]
13. Human tau increases amyloid β plaque size but not amyloid β-mediated synapse loss in a novel mouse model of Alzheimer's disease.
Jackson RJ; Rudinskiy N; Herrmann AG; Croft S; Kim JM; Petrova V; Ramos-Rodriguez JJ; Pitstick R; Wegmann S; Garcia-Alloza M; Carlson GA; Hyman BT; Spires-Jones TL
Eur J Neurosci; 2016 Dec; 44(12):3056-3066. PubMed ID: 27748574
[TBL] [Abstract][Full Text] [Related]
14. Patients that have Undergone Hemodialysis Exhibit Lower Amyloid Deposition in the Brain: Evidence Supporting a Therapeutic Strategy for Alzheimer's Disease by Removal of Blood Amyloid.
Sakai K; Senda T; Hata R; Kuroda M; Hasegawa M; Kato M; Abe M; Kawaguchi K; Nakai S; Hiki Y; Yuzawa Y; Kitaguchi N
J Alzheimers Dis; 2016; 51(4):997-1002. PubMed ID: 26923028
[TBL] [Abstract][Full Text] [Related]
15. Astrocytosis precedes amyloid plaque deposition in Alzheimer APPswe transgenic mouse brain: a correlative positron emission tomography and in vitro imaging study.
Rodriguez-Vieitez E; Ni R; Gulyás B; Tóth M; Häggkvist J; Halldin C; Voytenko L; Marutle A; Nordberg A
Eur J Nucl Med Mol Imaging; 2015 Jun; 42(7):1119-32. PubMed ID: 25893384
[TBL] [Abstract][Full Text] [Related]
16. Cholinergic degeneration is associated with increased plaque deposition and cognitive impairment in APPswe/PS1dE9 mice.
Laursen B; Mørk A; Plath N; Kristiansen U; Bastlund JF
Behav Brain Res; 2013 Mar; 240():146-52. PubMed ID: 23178660
[TBL] [Abstract][Full Text] [Related]
17. Deposition of mouse amyloid beta in human APP/PS1 double and single AD model transgenic mice.
van Groen T; Kiliaan AJ; Kadish I
Neurobiol Dis; 2006 Sep; 23(3):653-62. PubMed ID: 16829076
[TBL] [Abstract][Full Text] [Related]
18. N-truncated Aβ
Wirths O; Walter S; Kraus I; Klafki HW; Stazi M; Oberstein TJ; Ghiso J; Wiltfang J; Bayer TA; Weggen S
Alzheimers Res Ther; 2017 Oct; 9(1):80. PubMed ID: 28978359
[TBL] [Abstract][Full Text] [Related]
19. Chronic Verubecestat Treatment Suppresses Amyloid Accumulation in Advanced Aged Tg2576-AβPPswe Mice Without Inducing Microhemorrhage.
Villarreal S; Zhao F; Hyde LA; Holder D; Forest T; Sondey M; Chen X; Sur C; Parker EM; Kennedy ME
J Alzheimers Dis; 2017; 59(4):1393-1413. PubMed ID: 28800329
[TBL] [Abstract][Full Text] [Related]
20. Nitration of tyrosine 10 critically enhances amyloid β aggregation and plaque formation.
Kummer MP; Hermes M; Delekarte A; Hammerschmidt T; Kumar S; Terwel D; Walter J; Pape HC; König S; Roeber S; Jessen F; Klockgether T; Korte M; Heneka MT
Neuron; 2011 Sep; 71(5):833-44. PubMed ID: 21903077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
